Applied DNA Sciences Inc.

NASDAQ: APDN · Real-Time Price · USD
3.90
-0.17 (-4.18%)
At close: Aug 15, 2025, 3:59 PM
3.92
0.38%
After-hours: Aug 15, 2025, 06:13 PM EDT

Applied DNA Sciences Cash Flow Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Net Income
-7.42M -8.56M -7.02M -7.34M -12.33M -7.31M -10.02M -7.07M -5.08M -7.39M -8.27M -12.11M -14.44M -14.19M -14.28M -13.9M -13.74M -15.17M
Depreciation & Amortization
388.4K 456.05K 696.42K 949.12K 1.16M 1.32M 1.36M 1.36M 1.33M 1.31M 1.29M 1.26M 1.19M 1.07M 844.44K 626.83K 440.92K 308.07K
Stock-Based Compensation
116.07K 260.56K 572.29K 883.54K 1.19M 1.28M 1.03M 965.31K 898.18K 912.49K 2.52M 2.28M 2.42M 2.8M 1.67M 1.83M 1.79M 1.37M
Other Working Capital
-725.48K -756.28K -831.67K 676.1K 1.02M 1.4M 634.95K -916.4K -545.38K -1.06M -144.01K 304.58K -156.28K 68.44K -351.89K -300.26K -443.32K -212.07K
Other Non-Cash Items
-5.76M -3.98M -7.01M -8.36M -2.8M -7.33M -1.72M -3.47M -5.13M -2.66M -4.99M -1M 267.01K 229.21K 1.99M 947.79K 967.8K 1.79M
Deferred Income Tax
n/a n/a 628.05K 1.31M 1.31M 1.31M 684.12K n/a n/a n/a n/a n/a n/a n/a n/a 23.4K 45.28K 45.28K
Change in Working Capital
-542.34K -1.03M -1.14M -178.62K 851.28K 3.13M 2.45M 1.42M 1.28M 653K 954.57K -384.53K 632.92K -2.84M -3.62M -1.2M -2.92M -909.27K
Operating Cash Flow
-13.25M -13.28M -13.71M -13.14M -11.02M -7.59M -6.22M -6.8M -7.18M -7.66M -8.98M -10.43M -9.93M -12.93M -13.39M -11.66M -13.42M -12.57M
Capital Expenditures
-695.27K -524.78K -407.9K 80.42K -59.56K -99.07K -78.45K -438.18K -353.06K -364.25K -489.55K -1.15M -1.58M -2.32M -2.55M -2.65M -2.16M -1.36M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a 45K 45K 45K 45K n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a -1.04M -1.18M -1.18M -1.2M -158.22K -20.62K -20.62K n/a n/a n/a n/a n/a 36.52K 36.52K n/a
Investing Cash Flow
-695.27K -524.78K -407.9K -961.32K -1.1M -1.14M -1.1M -413.8K -328.68K -339.87K -489.55K -1.15M -1.58M -2.32M -2.55M -2.65M -2.16M -1.39M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.67M -1.67M -818.79K -818.79K
Common Stock Repurchased
n/a n/a n/a 952.5K 952.5K 952.5K 952.5K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
-38.83M n/a -77.76K -77.76K -77.76K -77.76K n/a n/a n/a n/a n/a n/a n/a n/a n/a -2.84K -2.84K -2.84K
Other Financial Acitivies
40.32M 589.64K 78.15K 78.15K 77.76K -2.88K n/a 3.7M 3.7M 7.79M 7.49M 3.79M 3.79M -291.6K 2.61M 3.47M 7.9M 10.66M
Financial Cash Flow
17.62M 19.74M 13.4M 13.79M 2.98M -35.08K n/a 14.03M 14.03M 18.13M 18.43M -10.31M -10.31M -639.95K n/a 15.56M 20.84M 9.54M
Net Cash Flow
3.67M 5.94M -720.71K -314.1K -9.14M -8.77M -7.31M 6.82M 6.52M 10.13M 8.66M -7.49M -7.41M -1.49M -1.23M 1.25M 5.26M -4.42M
Free Cash Flow
-13.95M -13.8M -14.12M -13.06M -11.08M -7.69M -6.3M -7.23M -7.53M -8.02M -9.47M -11.58M -11.51M -15.26M -15.94M -14.31M -15.58M -13.92M